TAV, scientific advice and Brexit in the focus of the meeting between PEI and the BPI
No matter whether the subject concerns the Therapieallergeneverordnung (TAV, Therapy Allergens Regulation), offers for regulatory scientific advice, or Brexit: These topics have in common that they require all actors to proceed in a harmonised manner.
"The active dialogue with associations of the pharmaceutical industry optimises the interfaces for development, marketing authorisation, and testing, and in doing so – ensures safe and effective biomedicines in Germany and Europe", explained Professor Klaus Cichutek, president of the PEI.
Ten-year study proves: Official batch testing of vaccines remains indispensible
Official batch testing of vaccines before marketing is compulsory by law in Germany. However, is it still required in view of modern vaccine production? Experts at the Paul-Ehrlich-Institute have performed a study on this matter with focus on batch testing in influenza (flu) vaccines in Europe over a period of ten years.
Survey on 'Safety for blood donors'
From 3 April 2018 to 30 September 2018, the Paul-Ehrlich-Institut (PEI) will be conducting a survey on the safety of donating blood. The aim of this survey is to obtain a representative view of physical reactions in connection with the blood collection. The survey addresses all blood donors regardless of when or how often they have donated or will donate blood during the period of the survey.